Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
28 Ergebnisse
| MG15FU |  | Neurocrine Biosciences Inc./Faktor/Long [2]/MS | - | - | call | Neurocrine Biosciences Inc. | 87,095 | 92,330 | 2,009 | 47,471 % | - | Morgan Stanley | |
| MJ0E7T | | Neurocrine Biosciences Inc./Faktor/Long [3]/MS | - | - | call | Neurocrine Biosciences Inc. | 116,126 | 123,100 | 3,058 | 29,965 % | - | Morgan Stanley | |
| MJ6KEQ | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 82,955 | 91,960 | 1,888 | 47,682 % | - | Morgan Stanley | |
| MK4AZW | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 67,067 | 67,067 | 1,599 | 61,844 % | - | Morgan Stanley | |
| MK4C1R | | Neurocrine Biosciences Inc./Faktor/Long [3]/MS | - | - | call | Neurocrine Biosciences Inc. | 116,126 | 123,100 | 3,066 | 29,965 % | - | Morgan Stanley | |
| MK5EAV | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 89,116 | 89,116 | 2,001 | 49,300 % | - | Morgan Stanley | |
| MK6B42 | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 110,937 | 110,937 | 2,673 | 36,885 % | - | Morgan Stanley | |
| MK6WQ6 | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 99,841 | 110,680 | 2,316 | 37,031 % | - | Morgan Stanley | |
| MM1ZCE | | Neurocrine Biosciences Inc./Faktor/Long [4]/MS | - | - | call | Neurocrine Biosciences Inc. | 130,642 | 138,490 | - | 21,210 % | - | Morgan Stanley | |
| MM1ZCF | | Neurocrine Biosciences Inc./Faktor/Long [5]/MS | - | - | call | Neurocrine Biosciences Inc. | 139,351 | 147,720 | - | 15,958 % | - | Morgan Stanley | |
| MM1ZCG | | Neurocrine Biosciences Inc./Faktor/Long [8]/MS | - | - | call | Neurocrine Biosciences Inc. | 152,416 | 161,570 | - | 8,079 % | - | Morgan Stanley | |
| MM1ZCH | | Neurocrine Biosciences Inc./Faktor/Long [10]/MS | - | - | call | Neurocrine Biosciences Inc. | 156,770 | 166,180 | - | 5,456 % | - | Morgan Stanley | |
| MM20H2 | | Neurocrine Biosciences Inc./Faktor/Short [5]/MS | - | - | put | Neurocrine Biosciences Inc. | 208,975 | 196,430 | - | 11,754 % | - | Morgan Stanley | |
| MM3TGR | | Neurocrine Biosciences Inc./KO/Put [endlos]/MS | - | - | put | Neurocrine Biosciences Inc. | 198,737 | 198,737 | - | 13,067 % | - | Morgan Stanley | |
| MN11NQ | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 75,300 | 83,470 | 1,736 | 52,512 % | - | Morgan Stanley | |
| MN4HCE | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 111,702 | 123,830 | 2,703 | 29,550 % | - | Morgan Stanley | |
| MN8PJF | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 122,429 | 122,429 | - | 30,347 % | - | Morgan Stanley | |
| MN8PXN | | Neurocrine Biosciences Inc./Faktor/Long [8]/MS | - | - | call | Neurocrine Biosciences Inc. | 152,416 | 161,570 | - | 8,079 % | - | Morgan Stanley | |
| MN8PXP | | Neurocrine Biosciences Inc./Faktor/Long [10]/MS | - | - | call | Neurocrine Biosciences Inc. | 156,770 | 166,180 | - | 5,456 % | - | Morgan Stanley | |
| MN8Q42 | | Neurocrine Biosciences Inc./Faktor/Short [4]/MS | - | - | put | Neurocrine Biosciences Inc. | 217,682 | 204,620 | - | 16,413 % | - | Morgan Stanley | |
| MN8Q43 | | Neurocrine Biosciences Inc./Faktor/Short [8]/MS | - | - | put | Neurocrine Biosciences Inc. | 195,914 | 184,150 | - | 4,768 % | - | Morgan Stanley | |
| MN8Q44 | | Neurocrine Biosciences Inc./Faktor/Short [10]/MS | - | - | put | Neurocrine Biosciences Inc. | 191,560 | 180,060 | - | 2,441 % | - | Morgan Stanley | |
| MN96CX | | Neurocrine Biosciences Inc./Faktor/Long [1,5]/MS | - | - | call | Neurocrine Biosciences Inc. | 58,063 | 61,550 | - | 64,983 % | - | Morgan Stanley | |
| MN9L0F | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 128,274 | 142,200 | 3,639 | 19,099 % | - | Morgan Stanley | |
| MR2RTZ | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 140,823 | 140,823 | - | 19,882 % | - | Morgan Stanley | |
| MR3G22 | | Neurocrine Biosciences Inc./KO/Call [endlos]/MS | - | - | call | Neurocrine Biosciences Inc. | 144,761 | 160,470 | - | 8,705 % | - | Morgan Stanley | |
| MR3HS1 | | Neurocrine Biosciences Inc./Faktor/Short [2]/MS | - | - | put | Neurocrine Biosciences Inc. | 261,219 | 245,540 | - | 39,694 % | - | Morgan Stanley | |
| MR3HS2 | | Neurocrine Biosciences Inc./Faktor/Short [3]/MS | - | - | put | Neurocrine Biosciences Inc. | 232,194 | 218,260 | - | 24,174 % | - | Morgan Stanley |